Catalyzing pathways for translational research beyond COVID-19

Abstract

Emergency action in response to the COVID-19 pandemic led to the removal of financial and regulatory barriers to developing medical technologies. But, as Andrea Armani and Eric Diebold explain, a broader cultural shift in academia can expedite their translation from laboratory benches to real-world use.